The application of growth factors in bone tissue engineering delivery systems and collaborative innovation strategies
Xu M., Cao H., Wu L.
Narrative Review on Face & Skin, Systemic / IV, published in Ann Med (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Ann Med (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42145120
- PMCID
- PMC13185072
- DOI
- 10.1080/07853890.2026.2670149
Abstract (original English)
Background Although bone tissue has inherent healing ability, bone regeneration of critical size defects still requires strategic intervention. As key signalling molecules, growth factors (GFs) coordinate bone formation and angiogenesis. However, their clinical application faces several challenges, including short half-lives, off-target effects and insufficient spatiotemporal control. Objective This article reviews the role of key GFs in bone tissue engineering (BTE) and critically evaluates advanced delivery systems based on the core translational concepts, aiming to promote safer and more effective bone repair methods. Content Moving beyond traditional material-based classifications, this review explores how biomaterial platforms achieve precise release kinetics and spatial control of key GFs, such as bone morphogenesis proteins (BMPs) and vascular endothelial growth factor (VEGF). In addition, it also emphasizes innovative strategies, including cell-based systems, stimulus response platforms and advanced manufacturing technologies such as 3D printing and electrostatic spinning. These strategies enhance the stability and target distribution of GFs. The key is that it describes safety problems and transformation obstacles, including off-target effect, ectopic bone formation and manufacturing scalability. Conclusion GFs continue to show great potential in the field of bone rege
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater